RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management
Abstract Aim The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR). Methods A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a prelim...
Gespeichert in:
| Veröffentlicht in: | Diabetes & metabolism 2011-04, Vol.37 (2), p.118-123 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 123 |
|---|---|
| container_issue | 2 |
| container_start_page | 118 |
| container_title | Diabetes & metabolism |
| container_volume | 37 |
| creator | Beynat, J Ben Mehidi, A Aubert, J.-P Bron, A.-M Massin, P Creuzot-Garcher, C |
| description | Abstract Aim The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR). Methods A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a preliminary test to evaluate their baseline level of knowledge. This allowed them free access to the entire website at any time with no time obligation. The website comprised a course of theoretical concepts and different types of training, including multiple-choice questionnaires (MCQ) focused on the course content, interpretation of diabetic fundus photographs and case reports. After perusing the entire RETIDIAB® website, users could take a second assessment test. Finally, they were asked to fill in a questionnaire evaluating the entire programme. Results A total of 137 users were registered and, of these, 109 took only the preliminary test, while 28 took the second test and evaluated the entire website; of the latter, 75% were residents and 25% were practising physicians, and 15 were male and 13 were female, ranging in age from 26 to 42 (30.2 ± 3) years. Statistically significant progress was seen between the first and second evaluations (37.3 ± 14% correct answers vs 64 ± 10%, respectively), and the average time interval between the first and second evaluations was 40 ± 20 days. In addition, users expressed a high level of overall satisfaction with the site. Conclusion This pilot study demonstrated the value and effectiveness of RETIDIAB® , a new CME website exclusively devoted to DR management. |
| doi_str_mv | 10.1016/j.diabet.2010.08.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00850869v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1262363610002363</els_id><sourcerecordid>863429412</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-965473a95221a3f7e896e39c7c47ccc0da45e23666a88a75f0fb6a9bee1f3f443</originalsourceid><addsrcrecordid>eNqFkstuEzEUhkcIREvhDRDyBiEWCceX8XhYIIVSaKRISFDWluOcaR1m7GDPBPJSPARPhodJi8SGjW0dfefi_z9F8ZTCnAKVr7bzjTNr7OcMcgjUHKC-V5xSVakZrRTcz28m2YxLLk-KRyltASiruXpYnDBKRVlV7LT48eniavluuXj76yd5TRYpYUod-p6Ehhhig--dH5y_Jh1unDUtwc1gTe-CJ99xnVyPpAmR9DdIXLeLYY-32dN0zpKYTx92pr85kM54c_0HeVw8aEyb8MnxPiu-vL-4Or-crT5-WJ4vVjMrKPSzWpai4qYuGaOGNxWqWiKvbWVFZa2FjRElMi6lNEqZqmygWUtTrxFpwxsh-Fnxcqp7Y1q9i64z8aCDcfpysdJjDECVoGS9p5l9MbH5I98GTL3uXLLYtsZjGJJWkgtWC8oyKSbSxpBSxOauNAU92qO3ehJAj_ZoULlPndOeHRsM6yzoXdKtHxl4fgRMymo30Xjr0l8ua6KkkJl7M3GYpds7jDpZh95mkyLaXm-C-98k_xawrfOjw1_xgGkbhuizLZrqxDToz-MqjZtEAWB88N9epsT2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>863429412</pqid></control><display><type>article</type><title>RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Beynat, J ; Ben Mehidi, A ; Aubert, J.-P ; Bron, A.-M ; Massin, P ; Creuzot-Garcher, C</creator><creatorcontrib>Beynat, J ; Ben Mehidi, A ; Aubert, J.-P ; Bron, A.-M ; Massin, P ; Creuzot-Garcher, C</creatorcontrib><description>Abstract Aim The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR). Methods A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a preliminary test to evaluate their baseline level of knowledge. This allowed them free access to the entire website at any time with no time obligation. The website comprised a course of theoretical concepts and different types of training, including multiple-choice questionnaires (MCQ) focused on the course content, interpretation of diabetic fundus photographs and case reports. After perusing the entire RETIDIAB® website, users could take a second assessment test. Finally, they were asked to fill in a questionnaire evaluating the entire programme. Results A total of 137 users were registered and, of these, 109 took only the preliminary test, while 28 took the second test and evaluated the entire website; of the latter, 75% were residents and 25% were practising physicians, and 15 were male and 13 were female, ranging in age from 26 to 42 (30.2 ± 3) years. Statistically significant progress was seen between the first and second evaluations (37.3 ± 14% correct answers vs 64 ± 10%, respectively), and the average time interval between the first and second evaluations was 40 ± 20 days. In addition, users expressed a high level of overall satisfaction with the site. Conclusion This pilot study demonstrated the value and effectiveness of RETIDIAB® , a new CME website exclusively devoted to DR management.</description><identifier>ISSN: 1262-3636</identifier><identifier>EISSN: 1878-1780</identifier><identifier>DOI: 10.1016/j.diabet.2010.08.009</identifier><identifier>PMID: 21145772</identifier><language>eng</language><publisher>Paris: Elsevier Masson SAS</publisher><subject>Adult ; Continuing medical education ; Diabetes mellitus ; Diabetic retinopathy ; Diabetic Retinopathy - therapy ; Diabète sucré ; Diabète. Anomalie tolérance glucose ; Dépistage ; E-learning ; Education, Medical, Continuing - methods ; Educational Measurement - methods ; Endocrinology & Metabolism ; Endocrinopathies ; Etiopathogénie. Dépistage. Explorations. Résistance tissu cible ; Female ; Food and Nutrition ; Formation médicale continue ; Fundus photography ; Humans ; Internal Medicine ; Internet ; Internship and Residency ; Life Sciences ; Male ; Oeil et annexes. Voies et centres visuels. Vision ; Ophtalmologie ; Ophthalmology ; Pancréas endocrine. Cellules apud (pathologie) ; Photographies du fond d’oeil ; Physicians ; Program Evaluation ; Rétinopathie diabétique ; Rétinopathies ; Sciences biologiques et medicales ; Sciences biologiques fondamentales et appliquees. Psychologie ; Sciences medicales ; Screening ; Surveys and Questionnaires ; Vertebres: systeme nerveux et organes des sens</subject><ispartof>Diabetes & metabolism, 2011-04, Vol.37 (2), p.118-123</ispartof><rights>Elsevier Masson SAS</rights><rights>2010 Elsevier Masson SAS</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Masson SAS. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-965473a95221a3f7e896e39c7c47ccc0da45e23666a88a75f0fb6a9bee1f3f443</citedby><cites>FETCH-LOGICAL-c410t-965473a95221a3f7e896e39c7c47ccc0da45e23666a88a75f0fb6a9bee1f3f443</cites><orcidid>0000-0002-7265-931X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1262363610002363$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24108646$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21145772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00850869$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Beynat, J</creatorcontrib><creatorcontrib>Ben Mehidi, A</creatorcontrib><creatorcontrib>Aubert, J.-P</creatorcontrib><creatorcontrib>Bron, A.-M</creatorcontrib><creatorcontrib>Massin, P</creatorcontrib><creatorcontrib>Creuzot-Garcher, C</creatorcontrib><title>RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management</title><title>Diabetes & metabolism</title><addtitle>Diabetes Metab</addtitle><description>Abstract Aim The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR). Methods A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a preliminary test to evaluate their baseline level of knowledge. This allowed them free access to the entire website at any time with no time obligation. The website comprised a course of theoretical concepts and different types of training, including multiple-choice questionnaires (MCQ) focused on the course content, interpretation of diabetic fundus photographs and case reports. After perusing the entire RETIDIAB® website, users could take a second assessment test. Finally, they were asked to fill in a questionnaire evaluating the entire programme. Results A total of 137 users were registered and, of these, 109 took only the preliminary test, while 28 took the second test and evaluated the entire website; of the latter, 75% were residents and 25% were practising physicians, and 15 were male and 13 were female, ranging in age from 26 to 42 (30.2 ± 3) years. Statistically significant progress was seen between the first and second evaluations (37.3 ± 14% correct answers vs 64 ± 10%, respectively), and the average time interval between the first and second evaluations was 40 ± 20 days. In addition, users expressed a high level of overall satisfaction with the site. Conclusion This pilot study demonstrated the value and effectiveness of RETIDIAB® , a new CME website exclusively devoted to DR management.</description><subject>Adult</subject><subject>Continuing medical education</subject><subject>Diabetes mellitus</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - therapy</subject><subject>Diabète sucré</subject><subject>Diabète. Anomalie tolérance glucose</subject><subject>Dépistage</subject><subject>E-learning</subject><subject>Education, Medical, Continuing - methods</subject><subject>Educational Measurement - methods</subject><subject>Endocrinology & Metabolism</subject><subject>Endocrinopathies</subject><subject>Etiopathogénie. Dépistage. Explorations. Résistance tissu cible</subject><subject>Female</subject><subject>Food and Nutrition</subject><subject>Formation médicale continue</subject><subject>Fundus photography</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Internet</subject><subject>Internship and Residency</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Oeil et annexes. Voies et centres visuels. Vision</subject><subject>Ophtalmologie</subject><subject>Ophthalmology</subject><subject>Pancréas endocrine. Cellules apud (pathologie)</subject><subject>Photographies du fond d’oeil</subject><subject>Physicians</subject><subject>Program Evaluation</subject><subject>Rétinopathie diabétique</subject><subject>Rétinopathies</subject><subject>Sciences biologiques et medicales</subject><subject>Sciences biologiques fondamentales et appliquees. Psychologie</subject><subject>Sciences medicales</subject><subject>Screening</subject><subject>Surveys and Questionnaires</subject><subject>Vertebres: systeme nerveux et organes des sens</subject><issn>1262-3636</issn><issn>1878-1780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkstuEzEUhkcIREvhDRDyBiEWCceX8XhYIIVSaKRISFDWluOcaR1m7GDPBPJSPARPhodJi8SGjW0dfefi_z9F8ZTCnAKVr7bzjTNr7OcMcgjUHKC-V5xSVakZrRTcz28m2YxLLk-KRyltASiruXpYnDBKRVlV7LT48eniavluuXj76yd5TRYpYUod-p6Ehhhig--dH5y_Jh1unDUtwc1gTe-CJ99xnVyPpAmR9DdIXLeLYY-32dN0zpKYTx92pr85kM54c_0HeVw8aEyb8MnxPiu-vL-4Or-crT5-WJ4vVjMrKPSzWpai4qYuGaOGNxWqWiKvbWVFZa2FjRElMi6lNEqZqmygWUtTrxFpwxsh-Fnxcqp7Y1q9i64z8aCDcfpysdJjDECVoGS9p5l9MbH5I98GTL3uXLLYtsZjGJJWkgtWC8oyKSbSxpBSxOauNAU92qO3ehJAj_ZoULlPndOeHRsM6yzoXdKtHxl4fgRMymo30Xjr0l8ua6KkkJl7M3GYpds7jDpZh95mkyLaXm-C-98k_xawrfOjw1_xgGkbhuizLZrqxDToz-MqjZtEAWB88N9epsT2</recordid><startdate>20110401</startdate><enddate>20110401</enddate><creator>Beynat, J</creator><creator>Ben Mehidi, A</creator><creator>Aubert, J.-P</creator><creator>Bron, A.-M</creator><creator>Massin, P</creator><creator>Creuzot-Garcher, C</creator><general>Elsevier Masson SAS</general><general>Masson</general><general>Elsevier Masson</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-7265-931X</orcidid></search><sort><creationdate>20110401</creationdate><title>RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management</title><author>Beynat, J ; Ben Mehidi, A ; Aubert, J.-P ; Bron, A.-M ; Massin, P ; Creuzot-Garcher, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-965473a95221a3f7e896e39c7c47ccc0da45e23666a88a75f0fb6a9bee1f3f443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>Continuing medical education</topic><topic>Diabetes mellitus</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - therapy</topic><topic>Diabète sucré</topic><topic>Diabète. Anomalie tolérance glucose</topic><topic>Dépistage</topic><topic>E-learning</topic><topic>Education, Medical, Continuing - methods</topic><topic>Educational Measurement - methods</topic><topic>Endocrinology & Metabolism</topic><topic>Endocrinopathies</topic><topic>Etiopathogénie. Dépistage. Explorations. Résistance tissu cible</topic><topic>Female</topic><topic>Food and Nutrition</topic><topic>Formation médicale continue</topic><topic>Fundus photography</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Internet</topic><topic>Internship and Residency</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Oeil et annexes. Voies et centres visuels. Vision</topic><topic>Ophtalmologie</topic><topic>Ophthalmology</topic><topic>Pancréas endocrine. Cellules apud (pathologie)</topic><topic>Photographies du fond d’oeil</topic><topic>Physicians</topic><topic>Program Evaluation</topic><topic>Rétinopathie diabétique</topic><topic>Rétinopathies</topic><topic>Sciences biologiques et medicales</topic><topic>Sciences biologiques fondamentales et appliquees. Psychologie</topic><topic>Sciences medicales</topic><topic>Screening</topic><topic>Surveys and Questionnaires</topic><topic>Vertebres: systeme nerveux et organes des sens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Beynat, J</creatorcontrib><creatorcontrib>Ben Mehidi, A</creatorcontrib><creatorcontrib>Aubert, J.-P</creatorcontrib><creatorcontrib>Bron, A.-M</creatorcontrib><creatorcontrib>Massin, P</creatorcontrib><creatorcontrib>Creuzot-Garcher, C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Diabetes & metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Beynat, J</au><au>Ben Mehidi, A</au><au>Aubert, J.-P</au><au>Bron, A.-M</au><au>Massin, P</au><au>Creuzot-Garcher, C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management</atitle><jtitle>Diabetes & metabolism</jtitle><addtitle>Diabetes Metab</addtitle><date>2011-04-01</date><risdate>2011</risdate><volume>37</volume><issue>2</issue><spage>118</spage><epage>123</epage><pages>118-123</pages><issn>1262-3636</issn><eissn>1878-1780</eissn><abstract>Abstract Aim The aim of this study was to evaluate the efficacy of a continuing medical education (CME) website to improve ophthalmological management of diabetic retinopathy (DR). Methods A worldwide website called RETIDIAB® was created in which, to log on for first time, users had to take a preliminary test to evaluate their baseline level of knowledge. This allowed them free access to the entire website at any time with no time obligation. The website comprised a course of theoretical concepts and different types of training, including multiple-choice questionnaires (MCQ) focused on the course content, interpretation of diabetic fundus photographs and case reports. After perusing the entire RETIDIAB® website, users could take a second assessment test. Finally, they were asked to fill in a questionnaire evaluating the entire programme. Results A total of 137 users were registered and, of these, 109 took only the preliminary test, while 28 took the second test and evaluated the entire website; of the latter, 75% were residents and 25% were practising physicians, and 15 were male and 13 were female, ranging in age from 26 to 42 (30.2 ± 3) years. Statistically significant progress was seen between the first and second evaluations (37.3 ± 14% correct answers vs 64 ± 10%, respectively), and the average time interval between the first and second evaluations was 40 ± 20 days. In addition, users expressed a high level of overall satisfaction with the site. Conclusion This pilot study demonstrated the value and effectiveness of RETIDIAB® , a new CME website exclusively devoted to DR management.</abstract><cop>Paris</cop><pub>Elsevier Masson SAS</pub><pmid>21145772</pmid><doi>10.1016/j.diabet.2010.08.009</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-7265-931X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1262-3636 |
| ispartof | Diabetes & metabolism, 2011-04, Vol.37 (2), p.118-123 |
| issn | 1262-3636 1878-1780 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00850869v1 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Continuing medical education Diabetes mellitus Diabetic retinopathy Diabetic Retinopathy - therapy Diabète sucré Diabète. Anomalie tolérance glucose Dépistage E-learning Education, Medical, Continuing - methods Educational Measurement - methods Endocrinology & Metabolism Endocrinopathies Etiopathogénie. Dépistage. Explorations. Résistance tissu cible Female Food and Nutrition Formation médicale continue Fundus photography Humans Internal Medicine Internet Internship and Residency Life Sciences Male Oeil et annexes. Voies et centres visuels. Vision Ophtalmologie Ophthalmology Pancréas endocrine. Cellules apud (pathologie) Photographies du fond d’oeil Physicians Program Evaluation Rétinopathie diabétique Rétinopathies Sciences biologiques et medicales Sciences biologiques fondamentales et appliquees. Psychologie Sciences medicales Screening Surveys and Questionnaires Vertebres: systeme nerveux et organes des sens |
| title | RETIDIAB® : Assessment of a continuing medical education website for the improvement of diabetic retinopathy management |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T05%3A04%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RETIDIAB%C2%AE%20:%20Assessment%20of%20a%20continuing%20medical%20education%20website%20for%20the%20improvement%20of%20diabetic%20retinopathy%20management&rft.jtitle=Diabetes%20&%20metabolism&rft.au=Beynat,%20J&rft.date=2011-04-01&rft.volume=37&rft.issue=2&rft.spage=118&rft.epage=123&rft.pages=118-123&rft.issn=1262-3636&rft.eissn=1878-1780&rft_id=info:doi/10.1016/j.diabet.2010.08.009&rft_dat=%3Cproquest_hal_p%3E863429412%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=863429412&rft_id=info:pmid/21145772&rft_els_id=S1262363610002363&rfr_iscdi=true |